Latest Bioethics Stories
HELSINKI, December 18, 2014 /PRNewswire/ -- Placebo-Controlled, Double-Blind Field Study on Jet Lag Treatment Followed by Development of New Smartphone
Data Demonstrate Therapeutic Levels of Clotting Factor for Hemophilia in Non-Human Primates and In Vivo Protein Production of Lysosomal Storage Disease Enzymes RICHMOND, Calif., Dec.
Dr. Mitchell Gaynor, acclaimed M.D.
- Secukinumab is the first selective IL-17A inhibitor to significantly improve signs and symptoms of ankylosing spondylitis (AS) versus placebo in Phase III studies EAST HANOVER, N.J., Nov.
The Congressman and architect of the Fattah Neuroscience Initiative will deliver opening remarks at the group's annual meeting in Washington next week WASHINGTON, Nov.
Pasteurized agave nectar and placebo were both perceived to be better by parents for treating nighttime cough and the resulting sleep difficulty in infants and toddlers than doing nothing at all
FLORHAM PARK, N.J., Oct.
- Afinitor led to an unprecedented median overall survival of 44 months, which represents a clinically meaningful while not statistically significant improvement(1) EAST HANOVER,
New research study “Global Biopower Market - Capacity, Generation, Market Size, Major Feedstock, Regulations, and Key Country Analysis to 2025” created by GlobalData is now available at MarketPublishers.com
The OncoMouse or Harvard Mouse is a type of laboratory mouse that has been genetically modified utilizing modification designed by Philip Leder and Timothy A. Stewart, of Harvard University, to carry a certain gene called an activated oncogene. The activated oncogene considerably increases the mouse’s vulnerability to cancer, therefore making the mouse suitable for cancer research. The rights to the invention were owned by DuPont until recently. The USPTO found that the patent expired in...
- A transitional zone between two communities containing the characteristic species of each.
More Images (1 images) »